有机磷农药中毒:肟类治疗的获益与局限
本文报告两例由久效磷和对硫磷引起的有机磷中毒病例,通过分光光度法测定乙酰胆碱酯酶和丁酰胆碱酯酶活性、酶可重活化性及血浆抑制潜力,并用气相色谱-电子电离质谱鉴定农药。病例1(久效磷)乙酰胆碱酯酶完全老化,肟类治疗不太可能获益;病例2(对硫磷)肟类治疗似乎是有效选择。作者指出缺乏大型临床试验证明双复磷和碘解磷定的临床获益,但强调廉价易行的分光光度法评估酶活性和可重活化性对避免不必要肟类治疗和识别获益患者至关重要。
要点
- 有机磷中毒后早期测定乙酰胆碱酯酶活性并结合临床病程,可指导肟类治疗决策。
- 病例1(久效磷)乙酰胆碱酯酶完全老化,肟类治疗不太可能获益。
- 病例2(对硫磷)肟类治疗似乎是有效治疗选择。
- 缺乏大型临床试验证明双复磷和碘解磷定在有机磷中毒中的临床相关获益。
- 分光光度法测定乙酰胆碱酯酶活性和可重活化性廉价易行,对避免不必要肟类治疗和识别获益患者至关重要。
适用人群与场景
- 有机磷农药中毒患者,包括久效磷和对硫磷中毒。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 早期测定乙酰胆碱酯酶活性,结合临床病程指导肟类治疗决策。
- 测定乙酰胆碱酯酶可重活化性:完全老化时肟类治疗不太可能获益(如病例1久效磷)。
- 可重活化时肟类治疗可能是有效选择(如病例2对硫磷)。
- 原文未提及具体肟类药物剂量、途径、频次或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为病例报告,样本量2例,无多中心。
- 病例1(久效磷):乙酰胆碱酯酶完全老化,肟类治疗不太可能获益。
- 病例2(对硫磷):肟类治疗似乎是有效治疗选择。
- 采用分光光度法测定乙酰胆碱酯酶和丁酰胆碱酯酶活性、可重活化性及血浆抑制潜力;气相色谱-电子电离质谱鉴定农药;液相色谱-电喷雾电离串联质谱定量阿托品血浆浓度;液相色谱-二极管阵列检测测定双复磷血浆浓度。
- 缺乏大型临床试验证明双复磷和碘解磷定在有机磷中毒中的临床相关获益。
证据类型、等级与局限
- 证据类型:病例报告(2例)。
- 局限:样本量小,无对照,缺乏大型临床试验证据。
对床旁实践的改变
- 对有机磷中毒患者,早期进行分光光度法测定乙酰胆碱酯酶活性和可重活化性,以指导肟类治疗决策。
- 乙酰胆碱酯酶完全老化时,避免不必要的肟类治疗。
- 可重活化时,考虑肟类治疗可能获益。
- 原文未提及具体适用与不适用人群的排除标准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Organophosphate pesticide poisoning remains a major global health problem, accounting for more than 100,000 deaths annually. For decades, the use of oximes in treating the manifestations of organophosphate poisoning has been controversial. We report two cases of organophosphate poisoning caused by monocrotophos and parathion that clearly illustrate both the benefits and the limitations of oxime therapy. These cases highlight the importance of the assessment of acetylcholinesterase activity for identifying patients that benefit from oxime treatment.
METHODS: We characterized two cases of organophosphate poisoning using spectrophotometric measurements of acetylcholinesterase and butyrylcholinesterase activity, the reactivatability of patients' acetylcholinesterase, and the inhibitory potential of patients' plasma. Gas chromatography-electron ionization mass spectrometry was used to identify the respective pesticides. In addition, liquid chromatography-electrospray ionization-tandem mass spectrometry was used to quantify atropine plasma concentrations and obidoxime plasma concentrations were determined by liquid chromatography coupled with diode-array detection.
CASE REPORTS: The two distinct cases of organophosphate poisoning demonstrate that an early determination of acetylcholinesterase activity, when interpreted alongside the clinical course, can guide clinical decision-making regarding oxime therapy. In the presence of completely aged acetylcholinesterase, as observed in case 1 (monocrotophos), oxime treatment is unlikely to be beneficial. In contrast, in case 2 (parathion), oxime therapy appears to be an effective therapeutic option.
DISCUSSION: Large clinical trials demonstrating a clinically relevant benefit of obidoxime and pralidoxime therapy in organophosphate poisoning are not available. Nevertheless, the present study shows that inexpensive and easy to perform spectrophotometric assessment of patient acetylcholinesterase activity and reactivatability is crucial for avoiding unnecessary oxime treatment and for clearly identifying patients who would benefit from this therapy.
CONCLUSION: Laboratory parameter-guided management of organophosphate poisoning, based on acetylcholinesterase activity, acetylcholinesterase reactivatability, and plasma inhibitory activity, supports clinical decision-making regarding oxime therapy.
参考来源
- Crepinsek J, Stark D, Steindl D, et al. Organophosphate pesticide poisoning: benefits and limitations of oxime therapy. Clin Toxicol (Phila). 2026. PMID: 42644717. doi:10.1080/15563650.2026.2707976
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。